DERMATA THERAPEUTICS INC (DRMA) Stock Income Statement
NASDAQ:DRMA - US2498454055 - Common Stock
5.898 USD
+0.12 (+2.06%)
5.4 USD
-0.5 (-8.44%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 10.54M | 12.51M | 8.04M | 9.67M | 7.86M | |||
| Research and Development | 6.49M | 8.20M | 4.07M | 5.65M | 3.46M | |||
| Selling, General, and Administrative Expenses | 4.05M | 4.31M | 3.97M | 4.02M | 4.40M | |||
| Operating Income | -10.54M | -12.51M | -8.04M | -9.67M | -7.86M | |||
| Interest Income/Expense | 209.70K | 225.80K | 247.20K | 63.60K | -45.60K | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | 0.00 | |||
| Income Before Taxes | -10.33M | -12.29M | -7.79M | -9.61M | -7.90M | |||
| Net Income | -10.33M | -12.29M | -7.79M | -9.61M | -10.46M | |||
| EBITDA | N/A | N/A | N/A | N/A | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -47.13 | -80.32 | -399.72 | -2.09K | -3.02K | |||
| Non GAAP EPS | -28.80 | -33.87 | -54.75 | -220.80 | N/A | |||
| Statistics | ||||||||
All data in USD